Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
XOMA Corporation logo

XOMA Corporation

Sector: Healthcare   

Industry: Biotechnology

25.64
 
USD
  
-0.45
  
(-1.72%)
Optionable: No  Market Cap: 303 M  90-day average vol: 18,896

Previous close: 26.09  Open: 26.14  Bid: 15.76  Ask: 27.0
52 week range    
13.48   
   27.00
Peers   
EBS / 
PFE / 
REGN / 
TEVA / 
NVS / 
LLY / 
Last updated: Thursday 25th April 2024
54
MarketXLS Rank
60
Value
61
Technical
42
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABBV

0.0401242 B33.1142.53

EBS

3 B11.145.67

LLY

0.0161238 B37.4243.55

NVS

PFE

0.0302298 B15.153.21

REGN

66 B9.7622.36

TEVA

Financials

XOMA Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends54 M-6 M13 M2 M-9 M-8 M23 M
Amortization of intangibles97000.0
Basic EPS total-1.43-0.36-3.5-8.890.75-0.35-0.230.820.69-1.98
Basic weighted shares outstanding87 M107 M6 M6 M8 M8 M9 M11 M11 M11 M
Depreciation-3 M-2 M-1 M-800000.0-300000.0-30000.0
Depreciation unreconciled97000.0
DepreciationAndAmortization-3 M-2 M-1 M-800000.0-300000.0-30000.097000.0
Diluted EPS total-1.43-0.67-3.5-8.890.73-1.59-0.230.780.65-1.98
Diluted weighted shares outstanding87 M115 M6 M6 M8 M8 M9 M12 M12 M11 M
GainOnSaleOfBusiness-61 M4 M
GainOnSaleOfPPE46 M
GainOnSaleOfSecurity-1000000.0
GeneralAndAdministrativeExpense-3 M-3 M-4 M18 M24 M19 M21 M17 M20 M23 M
Gross operating profit35 M19 M55 M6 M53 M5 M17 M28 M37 M4 M
Income before tax-124 M-38 M-21 M-54 M16 M-13 M-2 M12 M16 M-17 M
Income restructuring and M&A328000.084000.04 M5 M3 M2 M-15 M
Income taxes-14000.02 M-98000.0-2 M91000.0-15000.0
Interest income-61 M12 M-3 M-21000.0648000.0312000.0-320000.0-1 M
InterestExpenseNonOperating5 M4 M4 M4 M1 M922000.02 M2 M461000.0
InterestExpenseOperating2 M-3 M-2 M-2 M-545000.0
MiscOtherSpecialCharges-197000.048 M23 M12 M465000.05 M5 M3 M463000.02 M
Net income from total operations-124 M-38 M-21 M-54 M15 M-13 M-2 M13 M16 M-17 M
NetIncomeCommonStockholders-124 M-38 M-21 M-107 M20 M-13 M-4 M22 M24 M-40 M
NetIncomeContinuousOperations-124 M-38 M-21 M-54 M15 M-13 M-2 M13 M16 M-17 M
NetNonOperatingInterestIncomeExpense-66 M-4 M-4 M-4 M-1 M-922000.0-2 M-2 M-461000.0
Operating income-58 M-82 M-36 M-57 M20 M-15 M-5 M11 M16 M-19 M
Operating income before depreciation (EBITDA)-112 M-32 M-15 M-50 M18 M-12 M554000.014 M17 M-17 M
OperatingExpense-94 M-101 M-95 M-67 M-36 M-22 M-22 M-17 M-21 M-23 M
Other income net197000.0-48 M-23 M-12 M-465000.0-5 M-5 M-3 M-463000.0-2 M
OtherGandA-3 M-3 M-4 M18 M24 M19 M21 M17 M20 M23 M
OtherImpairmentOfCapitalAssets-200000.0-200000.0
OtherOperatingExpenses-94 M-101 M-95 M-67 M-36 M-22 M-22 M-177000.0-177000.0-177000.0
OtherunderPreferredStockDividend54 M-6 M13 M2 M-9 M-8 M23 M
PreferredStockDividends54 M-6 M13 M2 M-9 M-8 M23 M
RentAndLandingFees-3 M-3 M-4 M18 M24 M19 M21 M17 M20 M23 M
Research & development expense75 M81 M71 M44 M8 M2 M1 M170000.0171000.0153000.0
ResearchExpense75 M81 M71 M44 M8 M2 M1 M170000.0171000.0153000.0
RestructringAndMnAIncome328000.084000.04 M5 M3 M2 M-15 M
Revenue per share97000.0
SalariesAndWages-5 M-11 M-10 M-8 M-7 M-4 M-5 M-4 M-6 M
Selling Gen & administrative expense18 M20 M21 M18 M24 M19 M21 M17 M20 M23 M
SellingAndMarketingExpense18 M20 M21 M18 M
SellingExpense18 M20 M21 M18 M
Special income/charges-328000.0-84000.0-4 M-5 M-3 M-2 M15 M
Total Income available for interest expense (EBIT)-117 M-37 M-18 M-52 M17 M-13 M-63000.014 M16 M-17 M
Total common shares outstanding107 M116 M120 M8 M8 M9 M10 M11 M11 M11 M
Total net income-124 M-38 M-21 M-54 M15 M-13 M-2 M13 M16 M-17 M
Total ordinary shares12 M12 M12 M12 M12 M12 M12 M12 M12 M12 M
Total revenues35 M19 M55 M6 M53 M5 M17 M28 M37 M4 M
TotalExpenses-94 M-101 M-95 M-67 M-36 M-22 M-22 M-17 M-21 M-23 M
TotalRevenue35 M19 M55 M6 M52 M5 M17 M28 M37 M4 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University